Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 2.250% 9/0
-
Market price (% of par)
-
140.6%
-
Total 13F principal
-
$278,462,000
-
Principal change
-
+$277,365,000
-
Total reported market value
-
$391,317,367
-
Number of holders
-
23
-
Value change
-
+$389,762,191
-
Number of buys
-
22
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 2.250% 9/0 as of Q3 2025
As of 30 Sep 2025 ANI PHARMACEUTICALS INC - NOTE 2.250% 9/0 had 23 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $278,462,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Linden Advisors LP, CAMDEN ASSET MANAGEMENT L P /CA, BlackRock, Inc., HBK INVESTMENTS L P, Empyrean Capital Partners, LP, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, ABSOLUTE INVESTMENT ADVISERS, LLC, JPMORGAN CHASE & CO, and Polar Asset Management Partners Inc..
This table shows 23 bond principal holders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.